Hints and tips:
Related Special Reports
...Smith & Nephew had given a “compelling rationale” for paying more to its US-based leaders, Glass Lewis said....
...Smith & Nephew’s share price is down 8.3 per cent over the past 12 months and is up 1.6 per cent this year....
...Meanwhile, medical devices company Smith & Nephew wants to increase pay for its US executives to bring it closer to American levels....
...London Stock Exchange Group and Smith & Nephew are among the FTSE 100 companies hoping to follow AstraZeneca by pushing through pay increases for their executives at upcoming annual meetings....
...The former chief executive of outsourcing group Serco, and current chair of healthcare business Smith & Nephew, said the CBI still had an important role as a conduit between business and politicians....
Insurance group wants to back early-stage investments with a social purpose
...Smith & Nephew has warned that chip shortages are still hitting the medical device maker’s sales of surgical robotic technology and wound-protecting products, even as supply recovers at major chipmakers....
...For the 2023 financial year, Smith & Nephew is targeting revenue growth and trading profit margins above last year’s levels....
...A notable example from 2019 was Namal Nawana’s decision to quit Smith & Nephew after 18 months because the UK medical devices company could not meet his pay demands....
...RSGI research teamReena SenGupta, Yasmin Lambert, Mary Ormerod, Chris Sharp, Sarah Davis, Mina Jenkins, Molly Reynolds, Tom Saunders, Gitanjali DasGupta...
...In 2019, Namal Nawana, an Australian who had worked in the US, quit as chief executive of Smith & Nephew because the UK medical devices company could not meet his pay demands....
...of Britain’s wealthiest men, he told the court he could not afford to pay his ex-wife because he had handed control of the business empire he helped build with his late twin brother David to his three nephews...
...Morgan Stanley’s UK picks are mainly skewed towards bigger companies: BAE Systems, Ashtead, 3i, BP, Smith & Nephew, Haleon, Prudential, Rio Tinto, AstraZeneca, Invidior, Segro and SSE....
...Nath, who was previously president of diagnostics at Siemens Healthineers, will take the reins at Smith & Nephew from April 1....
...Medical devices maker Smith & Nephew has named Deepak Nath as its chief executive....
...Have your say Jenkins comments on Covid has been a catastrophe. Can it also be an opportunity? The first thing to be cheerful about is that it could have been so much worse....
...Smith & Nephew posted a 12.1 per cent drop in underlying revenue for 2020 and cautioned that disruption from Covid-19 was likely to continue for the first half of 2021....
...Smith+Nephew, the orthopaedic device maker, said it expects a fourth quarter underlying revenue decline of approximately 7 per cent....
...Smith & Nephew goes up to “overweight” at Morgan Stanley. A V-shaped recovery in kneecaps isn’t in the price, they say....
...Also out on Thursday is an update from FTSE 100 group Smith & Nephew....
...“Smith & Nephew is monitoring the Covid-19 outbreak closely, which introduces additional uncertainty,” the group said on Thursday....
...Join FT’s Hannah Kuchler and Colby Smith as they discuss science, the economy and the race to recovery in a series exploring our new economic reality on September 15. Sign up here....
...Smith & Nephew “lowers growth outlook amid coronavirus uncertainty” and its shares are up more than 8 per cent....
...Gayle Smith, president of the ONE Campaign against global poverty, says a lack of global co-ordination threatens to prolong the pandemic....
...Knees up Smith & Nephew has a spring back in its step....
International Edition